Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.
Zamberletti E, Viganò D, Guidali C, Rubino T, Parolaro D.
Int J Neuropsychopharmacol. 2012 Mar;15(2):267-80. doi: 10.1017/S1461145710001185. Epub 2010 Oct 6.
PMID:20923599
Microglial Activation and Psychotic Disorders: Evidence from Pre-clinical and Clinical Studies.
Barichello T, Simoes LR, Quevedo J, Zhang XY.
Curr Top Behav Neurosci. 2020;44:161-205. doi: 10.1007/7854_2018_81.
PMID:30828767
Acute schizophrenia-like psychosis as major clinical presentation of Graves’ disease successfully treated by radioiodine in combination with antipsychotics: a case report.
Dayu L, Yubo X, Bin J.
Actas Esp Psiquiatr. 2018 Nov;46(6):242-8. Epub 2018 Nov 1.
PMID:30552815
Cannabis-associated psychosis: current status of research.
Droperidol for psychosis-induced aggression or agitation.
Khokhar MA, Rathbone J.
Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD002830. doi: 10.1002/14651858.CD002830.pub3.
PMID:27976370
Lack of improvement at week 2 predicts later antipsychotic non-response in people with acute exacerbations of schizophrenia or schizophrenia-like psychosis.
Kishi T.
Evid Based Ment Health. 2016 May;19(2):61. doi: 10.1136/eb-2015-102180. Epub 2016 Mar 3.